Evolent Health, Inc.EVHNYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-6.13M
↑ 75% above average
Average (9y)
$-24.57M
Historical baseline
Range
High:$113.84M
Low:$-78.18M
CAGR
-15.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-6.13M | -105.4% |
| 2023 | $113.84M | +328.1% |
| 2022 | $-49.91M | -462.6% |
| 2021 | $13.76M | +130.1% |
| 2020 | $-45.70M | +41.5% |
| 2019 | $-78.18M | -29.9% |
| 2018 | $-60.20M | -7.9% |
| 2017 | $-55.81M | -9.3% |
| 2016 | $-51.04M | -93.7% |
| 2015 | $-26.34M | - |